with the latter expected to enter clinical trials in 2025 for hepatocellular carcinoma. The technology offers several advantages, including moderate potency to enable higher ADC dosing and ...

with the latter expected to enter clinical trials in 2025 for hepatocellular carcinoma. The technology offers several advantages, including moderate potency to enable higher ADC dosing and bystander ...

Aim: To compare the new, 6th edition, UICC TNM staging system with the former edition, we updated TNM staging in patients with differentiated thyroid carcinoma. Methods: The new and old TNM ...

The incidence of gastrointestinal cancers varies across Asian American, Native Hawaiian and other Pacific Islander communities, according to a study published March 15 in the journal Gastro Hep ...

The Center for AIDS Health Disparities Research (P.P., R.C., G.M., M.B., C.D.), Meharry Medical College, Nashville, TN. Department of Microbiology, Immunology, and ...